Pharmicell Co (XKRX:005690) Other Current Payables : ₩1,941 Mil (As of Mar. 2024)

View and export this data going back to 1988. Start your Free Trial

What is Pharmicell Co Other Current Payables?

Pharmicell Co's Other Current Payables for the quarter that ended in Mar. 2024 was ₩1,941 Mil.

Pharmicell Co's quarterly Other Current Payables declined from Sep. 2023 (₩1,613 Mil) to Dec. 2023 (₩1,468 Mil) but then increased from Dec. 2023 (₩1,468 Mil) to Mar. 2024 (₩1,941 Mil).

Pharmicell Co's annual Other Current Payables increased from Dec. 2021 (₩1,094 Mil) to Dec. 2022 (₩1,581 Mil) but then declined from Dec. 2022 (₩1,581 Mil) to Dec. 2023 (₩1,468 Mil).

Pharmicell Co Other Current Payables Historical Data

The historical data trend for Pharmicell Co's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmicell Co Other Current Payables Chart

Pharmicell Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Payables

Get a 7-Day Free Trial

756.84

459.07

1,094.23

1,581.24

1,468.46

Pharmicell Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Current Payables	Get a 7-Day Free Trial															1,652.42	1,437.67	1,612.59	1,468.46	1,940.99

Pharmicell Co Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Pharmicell Co Other Current Payables Related Terms

Thank you for viewing the detailed overview of Pharmicell Co's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmicell Co (XKRX:005690) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmicell Co Ltd (XKRX:005690) » Definitions » Other Current Payables

Comparable Companies

Traded in Other Exchanges

N/A

Address

12F Chungho B/D, 3-2 Nonhyun-dong Gangnam-gu, Seoul, KOR, 135-010

Website

http://www.pharmicell.com

Pharmicell Co Ltd is a biotechnology company, engages in the manufacturing of biopharmaceutical medicines in South Korea. Its biopharmaceutical business engages in the development and manufacture of stem cell therapeutic drugs and stem cell-based cosmetics and others. Its products under development include mesenchymal stem cell products, such as Cellgram_AMI, a heart disease drug; Cellgram_IS and Cellgram_SCI, which are brain/nerve disorder drugs; Cellgram_Lung, a pulmonary disease drug; Cellgram_LC, a liver disease drug; and Cellgram_ED and Cellgram_CLI for the treatment of graft-versus-host disease, kidney transplant, impotence, and critical lower limb ischemia.

Pharmicell Co (XKRX:005690) Headlines

No Headlines